Value through Innovation27 July 2016

Clinical Study Results

  • BI 831266 - Neoplasms
    Clinical Study Number 1257.1
    Study Indication Neoplasms
    Product BI 831266
    Generic Name BI 831266
    Lab Code
    Clinical Phase I
    Study Title

    An open-label phase I single dose escalation trial of two dosing schedules of BI 831266 administered intravenously over 24 h continuously in patients with advanced solid tumours

    Study Document Trial synopsis 1257.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.